Staar Surgical (NSDQ:STAA) posted fourth-quarter results that beat the consensus forecast on Wall Street. The Monrovia, Calif.-based company reported profits of $6.4 million, or 14¢ per share, on sales of $38.9 million for the three months ended Jan. 3, 2020, for a bottom-line gain of 482% sales growth of 24.7% compared with Q4 2018. Adjusted to […]
Inogen reports Q4 misses, reduced guidance
Inogen (NSDQ:INGN) shares skyrocketed today on fourth-quarter results that missed the consensus earnings forecast but beat The Street’s sales projections. The Goleta, Calif.-based home oxygen generator maker posted losses of -$1.4 million, or -6¢ per share, on sales of $78.9 million for the three months ended Dec. 31, 2019, sliding into losses after posting profits […]
Nevro shares rise with Street-beating Q4 results
Nevro (NYSE:NVRO) reported fourth-quarter results today that beat the consensus forecast on Wall Street. The Redwood City, Calif.-based company reported losses of -$13.7 million, or -44¢ per share, on sales of $114.3 million for the three months ended Dec. 31, 2019, for sales growth of 5.9% compared with Q4 2018. Earnings per share were -44¢, 19¢ […]
Inspire Medical Systems posts Street-beating Q4 results
Inspire Medical Systems (NYSE:INSP) posted fourth-quarter results that beat the consensus on Wall Street. The Minneapolis-based company reported losses of $9.1 million, or -38¢ per share, on sales of $26.9 million for the three months ended Dec. 31, 2019, for a sales growth of 62.5% compared with Q4 2018. Earnings per share were -38¢, 2¢ ahead […]
SmileDirectClub stocks plunge amid Q4 losses
SmileDirectClub (NSDQ:SDC) today posted fourth-quarter results that missed the consensus forecast on Wall Street. The Nashville, Tenn.-based company reported losses of -$97.3 million, or -25¢ per share, on sales of $196.7 million for the three months ended Dec. 31, 2019, for a sales growth of 53.1% compared with Q4 2018. Earnings per share were -25¢, 14¢ […]
LivaNova beats on Q4 earnings, misses on revenue
LivaNova (NSDQ:LIVN) shares took a slight dip today on fourth-quarter results that beat the consensus projections for earnings but came up short on revenue. The London-based medical device company posted losses of -$143.2 million, or -$2.96 per share, on sales of $287.6 million for the three months ended Dec. 31, 2019, for a 32% bottom-line gain […]
Insulet down after hours on Q4 sales beat, bottom-line slide
Insulet (NSDQ:PODD) shares took a further hit today after sliding in the market following the release of the company’s quarterly earnings. The company’s shares sunk after-hours yesterday on fourth-quarter results that beat the consensus forecast for revenue but appeared to miss on earnings. Today, shares of PODD are down -8.4% at $180.18 per share in mid-afternoon […]
Orthofix plummets after hours on missed projections
Orthofix Medical (NSDQ:OFIX) shares took a hit after hours today on fourth-quarter results that missed the forecasts made by Wall Street. OFIX shares were down -14.4% at $38.51 per share after hours this evening. The Lewisville, Texas-based orthopedic device company posted profits of $11.7 million, or 60¢ per share, on sales of $121.5 million for the […]
Intersect ENT’s Q4 beats Street despite losses
Intersect ENT (NSDQ:XENT) shares dipped today on fourth-quarter losses that topped the consensus forecast. The Menlo Park, Calif.-based ear, nose and throat condition treatment developer posted losses of -$7.96 million, or -25¢ per share, on sales of $31.75 million for the three months ended Dec. 31, 2019, for a nearly $3 million bottom-line slide on a […]
NuVasive down despite doubled Q4 profits
NuVasive (NSDQ:NUVA) shares are down today despite fourth-quarter results that easily topped the consensus forecast and revealed more than double the profits compared to the same time last year. The San Diego-based spine technology company posted profits of $29.9 million, or 55¢ per share, on sales of $310.4 million for the three months ended Dec. 31, […]
Judge tosses Abbott’s bid to dismiss Tendyne investors’ $50m claim
Abbott (NYSE:ABT) has lost a bid to dismiss a lawsuit by former investors in Tendyne Holdings, who claim that the healthcare giant dragged its heels on obtaining a regulatory approval that would have triggered a $50 million milestone payment. Abbott in September 2015 paid $225 million up front for the stake it didn’t already own in […]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 566
- Next Page »
